vantictumab

Vantictumab Placed on Partial Clinical Hold by FDA Following Voluntary Halt by OncoMed
Yahoo/Globe Newswire
Sat, 06/14/14 - 09:22 am
vantictumab
OncoMed
OncoMed initiates second Phase 1b clinical trial of vantictumab
Yahoo/AP
Fri, 11/15/13 - 11:25 am
OncoMed
vantictumab
non-small cell lung cancer
OncoMed Pharmaceuticals Presents Updated Phase 1a Data in Advanced Solid Tumor Patients for the First-in-Class WNT-Pathway-Targeting Antibody Vantictumab (OMP-18R5) at the European Cancer Congress 2013
Yahoo/GlobeNewsWire
Sun, 09/29/13 - 01:32 pm
vantictumab
OMP-18R5
neuroendocrine tumors
OncoMed
solid tumors